lucius卢修斯 凡德他尼 Vandetanib甲状腺髓样癌

凡德他尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Vandetanib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Each film-coated tablet contain

LUCiUS

甲状腺髓样癌

Iadication:

PHARMACEUTICALS

Luci Vande is a kinase inhibitor indicated for the
treatment of symptomatic or progressive medullary
yrolo cancer in patients with unresestab
ced or metastatic disease
Use LuciVande in patien

dow ly progressing disease only

LuciVande 300

Vandetanib Tablets

FDA批准

"LuciVande may be ta
Deceetaket with or without food.
Dosage reduction may bo

Rx Only

severe to riee yathe event o

300mg

Morage: in a dry place and store at 20°C to 25°C
Warning
Keep medicine out of reach of Children. Do no
adonister Luci Vande during Pregnaney and
Lactatioa

PLEASE SEE PACKAGE INSERT

权威认证

Manufactured and Marketed

LUCIUS

Thongmang village, Xaythany district,
Vientiane Capital.Laos
Warning : To be sold by retlon steserinfo
of registered physicians only, and as directa

口碑质量

ue poysician.

30 Tablets

适应症:
凡德他尼是一种激酶抑制剂,用于治疗无法切除的局部晚期或转移
性甲状腺髓样癌患者的症状性或进展性甲状腺髓样癌。
对于惰性、无症状或进展缓慢的患者,仅在仔细考虑凡德他尼的治疗
相关风险后,才可使用凡德他尼。
推荐剂量:
·每日一次,每次300mg。
·可与食物同服或单独服用。
· 如 果 出 现 严 重 毒 性 或 QTc 间 期 延 长 , 可 能 需 要 减 少 剂
·中度肾功能不全患者的起始剂量为200mg。